Pramipexole

Known as: (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine, 4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine, Pramipexol 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2018
05019902018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND Depression is common in patients with Parkinson's disease, but evidence on the efficacy of antidepressants in this… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Continuous dopaminergic drug delivery is an unmet medical need in advanced Parkinson's disease. The aim of this trial… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVE To assess the efficacy and safety of pramipexole, a dopamine 3 receptor agonist, in patients with fibromyalgia… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE Previous studies suggest that the dopamine agonist pramipexole may possess antidepressant properties. The authors… (More)
  • table 1
Is this relevant?
Highly Cited
2002
Highly Cited
2002
  • JAMA
  • 2002
CONTEXT Pramipexole and levodopa are effective medications to treat motor symptoms of early Parkinson disease (PD). In vitro and… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
CONTEXT Pramipexole and levodopa both ameliorate the motor symptoms of early Parkinson disease (PD), but no controlled studies… (More)
  • table 2
  • table 3
  • figure 3
  • table 5
  • figure 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Pramipexole, a dopamine D2 receptor agonist, was tested in 174 patients with major depression, with or without melancholia and… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The authors report a new side effect of the dopamine agonists pramipexole and ropinirole: sudden irresistible attacks of sleep… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
A total of 335 patients with early Parkinson's disease (PD) were enrolled in a multicenter, randomized, double-blind trial… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Pramipexole is a new, selective, nonergoline dopamine agonist that acts on D2 and preferentially on D3 dopamine receptors. Phase… (More)
Is this relevant?